Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Aug 07, 2026
Why Is Coherent Corp. (COHR) Stock Up +13.41% Today?

Why Is Coherent Corp. (COHR) Stock Up +13.41% Today?

Key Takeaways

  • Coherent Corp. (COHR) surged 13.41% on Friday, closing at $379.05 versus a prior session close of $334.22, adding $44.83 per share.
  • The primary catalyst was a sector-wide rally in optical and photonics stocks after Applied Optoelectronics (AAOI) reported blowout quarterly results, nearly doubling revenue and returning to profitability.
  • A Reuters report that the Trump administration and the FCC are drafting a ban on imports of new Chinese optical transceivers provided an additional regulatory tailwind for U.S.-based suppliers like Coherent.
  • A weaker-than-expected July jobs report tempered expectations for further Federal Reserve rate hikes, boosting growth-oriented technology names across the board.
  • Coherent is scheduled to report its own fiscal fourth-quarter results on August 12, with analysts projecting revenue near $1.99 billion and strong year-over-year earnings growth.
  • Traders are closely watching whether the stock can sustain momentum into next week's earnings release and whether the proposed FCC restrictions materialize.

Opening Summary

COHR, the stock of Coherent Corp. — a Pittsburgh-based global leader in lasers, optical components, and photonics solutions serving data center, industrial, communications, and electronics markets — rocketed 13.41% higher in Friday's trading session. Shares closed at $379.05, up sharply from Thursday's close of $334.22, as a confluence of favorable catalysts ignited a powerful rally across the optical communications sector. The move extended a dramatic recovery from the stock's late-July lows and underscored intensifying investor enthusiasm for companies positioned at the intersection of artificial intelligence infrastructure and photonics technology.

Sector-Wide Rally Fueled by Applied Optoelectronics Earnings

The single most powerful trigger for Friday's surge was the exceptional quarterly report from peer AAOI (Applied Optoelectronics). The company posted its fifth consecutive record quarter, with second-quarter 2026 revenue soaring 86% year-over-year to approximately $192 million. More importantly, Applied Optoelectronics swung from a prior-year loss to non-GAAP profitability, comfortably exceeding consensus estimates on both the top and bottom lines. Management struck a notably bullish tone on the earnings call, stating that demand for AI networking products is so intense that near-term sales are "constrained almost exclusively by manufacturing capacity and the availability of key components," with demand forecasts projected to outstrip capacity well into mid-2027.

The read-across for COHR was immediate and powerful. As a leading manufacturer of high-speed optical transceivers, including 800G and 1.6T products critical for AI data center interconnects, Coherent is a direct beneficiary of the same AI infrastructure spending wave that drove Applied Optoelectronics' results. Investors rapidly rotated into the broader optical and photonics universe, lifting LITE (Lumentum), MRVL (Marvell Technology), and GLW (Corning) alongside Coherent.

FCC's Proposed Ban on Chinese Optical Transceivers Adds Regulatory Tailwind

Compounding the earnings-driven momentum, a Reuters report confirmed that the Trump administration — through the Federal Communications Commission — is actively drafting rules to prohibit imports of new Chinese-manufactured optical transceivers into U.S. data centers. The proposed restrictions, which officials aim to publish before year-end, target components that convert electrical signals to light in fiber-optic networks and are framed around cybersecurity concerns including potential malware, data collection, and service disruption risks.

For COHR, the implications are significant. Chinese manufacturer Zhongji Innolight currently commands roughly 27% of the global data center transceiver market, according to Counterpoint Research. A ban would effectively redirect procurement by hyperscalers — including Amazon Web Services, Microsoft Azure, Google Cloud, and Meta — toward U.S.-based alternatives, with Coherent and Lumentum positioned as the primary domestic beneficiaries. Coherent's competitive edge is further reinforced by Nvidia's strategic $2 billion investment in the company and multi-year procurement agreements securing next-generation co-packaged optics production capacity.

Macroeconomic Backdrop: Softer Jobs Data Eases Rate-Hike Fears

Friday's rally also received a meaningful boost from the macroeconomic environment. The July U.S. employment report came in weaker than economists had forecast, with job creation slowing more than anticipated. The soft data print significantly reduced market expectations for an additional Federal Reserve interest rate hike at the September policy meeting. Lower rate-hike probabilities translated into lower bond yields, which in turn improved the relative attractiveness of growth-oriented technology equities — precisely the category into which Coherent falls, trading at elevated forward earnings multiples tied to its AI-driven growth narrative. The NASDAQ 100 and the iShares Semiconductor ETF (SOXX) both advanced during the session, providing a favorable backdrop.

Market Context and Trading Activity

Friday's explosive move extends a remarkable recovery for COHR. The stock hit an all-time high of $440 in early June before a brutal summer selloff carved 49.8% off its value, bottoming at $220.68 on July 29. Since that trough, shares have now recovered approximately 72% in just over a week of trading. The rally has been supported by heavy volume; Thursday's session alone saw over 6 million shares change hands, and Friday's activity was similarly elevated relative to historical averages. The stock has now decisively broken back above its 50-day moving average, a technical signal that algorithmic and momentum-driven traders often treat as a bullish confirmation.

The broader photonics and optical networking complex moved in sympathy throughout the week. The initial spark came on August 4, when the FCC transceiver ban report first surfaced, triggering a four-day advance that lifted Applied Optoelectronics by 72% and Coherent by approximately 46% through Thursday's close — before Friday added another 13% to the tally.

What Comes Next for COHR

The spotlight now shifts squarely to Coherent's own financial results. The company is scheduled to report fiscal fourth-quarter 2026 earnings on August 12, after the New York Stock Exchange closing bell. Wall Street analysts are projecting revenue of approximately $1.99 billion and non-GAAP earnings per share of roughly $1.43, which would represent a 93% year-over-year increase. Management previously guided for revenue in a range of $1.91 billion to $2.05 billion, with EPS between $1.52 and $1.72.

Analyst sentiment remains decidedly bullish heading into the print. JPMorgan maintains an Overweight rating with a $435 price target, while Raymond James carries a Strong Buy at the same target level. Of 23 analysts covering the stock, 16 rate it a Strong Buy. However, risks remain: the FCC transceiver ban remains a proposal that could be modified or shelved; Coherent's premium valuation — trading at roughly 59 times forward adjusted earnings — leaves limited room for disappointment; and the broader macroeconomic trajectory, including the pace of AI infrastructure spending by hyperscalers, will continue to shape sentiment. Investors should also monitor developments around indium phosphide (InP) supply chains, a critical raw material where U.S. manufacturers maintain some dependence on Chinese suppliers — a factor that could complicate any hard regulatory cutoff.

Trending AI Robots

For traders seeking systematic exposure to stocks like COHR without the emotional challenges of discretionary decision-making, Tickeron's Trending AI Robots page offers a carefully curated view of AI-powered trading bots actively navigating current market conditions. Tickeron hosts hundreds of algorithmic trading bots spanning thousands of tickers across diverse strategies, timeframes, and performance metrics — but only the strongest, most adaptive performers under prevailing market dynamics are featured in the Trending AI Robots section. Whether your focus is momentum, trend-following, or mean-reversion, exploring this curated selection can help you identify data-driven approaches aligned with today's fast-moving markets.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: COHR

Contributor

<p>Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years&nbsp;developing&nbsp;his proprietary trading and quantitative algorithms (now Tickeron&rsquo;s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional,&nbsp;sophisticated stock market analysis capabilities to retail investors via&nbsp;an easy-to-use interface.</p>


COHR in upward trend: price rose above 50-day moving average on August 07, 2026

COHR moved above its 50-day moving average on August 07, 2026 date and that indicates a change from a downward trend to an upward trend. In of 27 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 03, 2026. You may want to consider a long position or call options on COHR as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for COHR just turned positive on August 04, 2026. Looking at past instances where COHR's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where COHR advanced for three days, in of 339 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The 10-day moving average for COHR crossed bearishly below the 50-day moving average on July 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

COHR broke above its upper Bollinger Band on August 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for COHR entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. COHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.949) is normal, around the industry mean (4.515). P/E Ratio (180.538) is within average values for comparable stocks, (88.451). COHR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.191). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (10.352) is also within normal values, averaging (30.513).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Industry description

This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.

Market Cap

The average market capitalization across the Electronic Equipment/Instruments Industry is 9.61B. The market cap for tickers in the group ranges from 27.54K to 122.53B. KYCCF holds the highest valuation in this group at 122.53B. The lowest valued company is CSEC at 27.54K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Equipment/Instruments Industry was 2%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 8%. FCUV experienced the highest price growth at 337%, while MVIS experienced the biggest fall at -94%.

Volume

The average weekly volume growth across all stocks in the Electronic Equipment/Instruments Industry was -11%. For the same stocks of the Industry, the average monthly volume growth was 9% and the average quarterly volume growth was -33%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 55
Price Growth Rating: 50
SMR Rating: 79
Profit Risk Rating: 77
Seasonality Score: -10 (-100 ... +100)
View a ticker or compare two or three
COHR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a maker of laser diodes and other laser equipment

Industry ElectronicEquipmentInstruments

Profile
Details
Industry
Electronic Equipment Or Instruments
Address
375 Saxonburg Boulevard
Phone
+1 724 352-4455
Employees
26622
Web
https://www.ii-vi.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.